+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Psoriasis Market and Competitive Landscape - 2020

  • ID: 5023382
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
The research report Global Psoriasis Market and Competitive Landscape - 2020, provides comprehensive insights into the Psoriasis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Psoriasis market size and drug sales. It also provides insights into Psoriasis epidemiology and late stage pipeline.

This research covers the following: Psoriasis treatment options, Psoriasis late stage clinical trials pipeline, Psoriasis prevalence by countries, Psoriasis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Psoriasis pipeline: Find out drugs in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Psoriasis epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis by countries
  • Psoriasis drugs: Identify key drugs marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company
  • Psoriasis drugs sales: Find out the sales value for Psoriasis drugs by countries
  • Psoriasis market valuations: Find out the market size for Psoriasis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Psoriasis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Psoriasis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Psoriasis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Psoriasis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Psoriasis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
1. Psoriasis Treatment Options

2. Psoriasis Pipeline Insights
2.1. Psoriasis Phase 3 Clinical Trials
2.2. Psoriasis Phase 2 Clinical Trials
2.3. Psoriasis Phase 1 Clinical Trials

3. Psoriasis Epidemiology Analysis by Countries

4. US Psoriasis Market Insights
4.1. Marketed Drugs for Psoriasis in US
4.2. US Psoriasis Market Size & Forecast
4.3. US Psoriasis Drugs Sales & Forecast
4.4. US Psoriasis Market Share Analysis

5. Germany Psoriasis Market Insights
5.1. Marketed Drugs for Psoriasis in Germany
5.2. Germany Psoriasis Market Size & Forecast
5.3. Germany Psoriasis Drugs Sales Forecast
5.4. Germany Psoriasis Market Share Analysis

6. France Psoriasis Market Insights
6.1. Marketed Drugs for Psoriasis in France
6.2. France Psoriasis Market Size & Forecast
6.3. France Psoriasis Product Sales Forecast
6.4. France Psoriasis Market Share Analysis

7. Italy Psoriasis Market Insights
7.1. Marketed Drugs for Psoriasis in Italy
7.2. Italy Psoriasis Market Size & Forecast
7.3. Italy Psoriasis Product Sales Forecast
7.4. Italy Psoriasis Market Share Analysis

8. Spain Psoriasis Market Insights
8.1. Marketed Drugs for Psoriasis in Spain
8.2. Spain Psoriasis Market Size & Forecast
8.3. Spain Psoriasis Product Sales Forecast
8.4. Spain Psoriasis Market Share Analysis

9. UK Psoriasis Market Insights
9.1. Marketed Drugs for Psoriasis in UK
9.2. UK Psoriasis Market Size & Forecast
9.3. UK Psoriasis Product Sales Forecast
9.4. UK Psoriasis Market Share Analysis

10. Europe Psoriasis Market Insights
10.1. Europe Psoriasis Market Size & Forecast
10.2. Europe Psoriasis Product Sales Forecast
10.3. Europe Psoriasis Market Share Analysis

11. Japan Psoriasis Market Insights
11.1. Marketed Drugs for Psoriasis in Japan
11.2. Japan Psoriasis Market Size & Forecast
11.3. Japan Psoriasis Product Sales Forecast
11.4. Japan Psoriasis Market Share Analysis

12. Global Psoriasis Market Insights
12.1. Global Psoriasis Market Size & Forecast
12.2. Global Psoriasis Product Sales Forecast
12.3. Global Psoriasis Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Psoriasis Phase 3 Clinical Trials, Global, 2020
Table 2: Psoriasis Phase 2 Clinical Trials, Global, 2020
Table 3: Psoriasis Phase 1 Clinical Trials, Global, 2020
Table 4: Psoriasis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Psoriasis in US, 2019
Table 6: US Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Psoriasis Product Sales ($mn), 2016 - 2024
Table 8: US Psoriasis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Psoriasis in Germany, 2019
Table 10: Germany Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Psoriasis Product Sales ($mn), 2016 - 2024
Table 12: Germany Psoriasis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Psoriasis in France, 2019
Table 14: France Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Psoriasis Product Sales ($mn), 2016 - 2024
Table 16: France Psoriasis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Psoriasis in Italy, 2019
Table 18: Italy Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Psoriasis Product Sales ($mn), 2016 - 2024
Table 20: Italy Psoriasis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Psoriasis in Spain, 2019
Table 22: Spain Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Psoriasis Product Sales ($mn), 2016 - 2024
Table 24: Spain Psoriasis Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Psoriasis in UK, 2019
Table 26: UK Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Psoriasis Product Sales ($mn), 2016 - 2024
Table 28: UK Psoriasis Market Events and Trends, 2016 - 2024
Table 29: Europe Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Psoriasis Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Psoriasis in Japan, 2019
Table 32: Japan Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Psoriasis Product Sales ($mn), 2016 - 2024
Table 34: Japan Psoriasis Market Events and Trends, 2016 - 2024
Table 35: Global Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Psoriasis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Psoriasis Pipeline by Phase (%), Global, 2020
Figure 2: Psoriasis Prevalence by Countries, 2016 - 2024
Figure 3: US Psoriasis Market Size ($mn), 2016 - 2024
Figure 4: US Psoriasis Product Sales ($mn), 2016 - 2024
Figure 5: US Psoriasis Market Share by Drugs (%), 2019
Figure 6: US Psoriasis Market - Future Market Share (%), 2024
Figure 7: Germany Psoriasis Market Size ($mn), 2016 - 2024
Figure 8: Germany Psoriasis Product Sales ($mn), 2016 - 2024
Figure 9: Germany Psoriasis Market Share by Drugs (%), 2019
Figure 10: Germany Psoriasis Market - Future Market Share (%), 2024
Figure 11: France Psoriasis Market Size ($mn), 2016 - 2024
Figure 12: France Psoriasis Product Sales ($mn), 2016 - 2024
Figure 13: France Psoriasis Market Share by Drugs (%), 2019
Figure 14: France Psoriasis Market - Future Market Share (%), 2024
Figure 15: Italy Psoriasis Market Size ($mn), 2016 - 2024
Figure 16: Italy Psoriasis Product Sales ($mn), 2016 - 2024
Figure 17: Italy Psoriasis Market Share by Drugs (%), 2019
Figure 18: Italy Psoriasis Market - Future Market Share (%), 2024
Figure 19: Spain Psoriasis Market Size ($mn), 2016 - 2024
Figure 20: Spain Psoriasis Product Sales ($mn), 2016 - 2024
Figure 21: Spain Psoriasis Market Share by Drugs (%), 2019
Figure 22: Spain Psoriasis Market - Future Market Share (%), 2024
Figure 23: UK Psoriasis Market Size ($mn), 2016 - 2024
Figure 24: UK Psoriasis Product Sales ($mn), 2016 - 2024
Figure 25: UK Psoriasis Market Share by Drugs (%), 2019
Figure 26: UK Psoriasis Market - Future Market Share (%), 2024
Figure 27: Europe Psoriasis Market Size ($mn), 2016 - 2024
Figure 28: Europe Psoriasis Product Sales ($mn), 2016 - 2024
Figure 29: Europe Psoriasis Market Share by Drugs (%), 2019
Figure 30: Europe Psoriasis Market - Future Market Share (%), 2024
Figure 31: Japan Psoriasis Market Size ($mn), 2016 - 2024
Figure 32: Japan Psoriasis Product Sales ($mn), 2016 - 2024
Figure 33: Japan Psoriasis Market Share by Drugs (%), 2019
Figure 34: Japan Psoriasis Market - Future Market Share (%), 2024
Figure 35: Global Psoriasis Market Size ($mn), 2016 - 2024
Figure 36: Global Psoriasis Product Sales ($mn), 2016 - 2024
Figure 37: Global Psoriasis Market Share by Drugs (%), 2019
Figure 38: Global Psoriasis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll